Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis?

Anadolu Kardiyoloji Dergisi

Volumn 15, Issue 5, 2015, Pages 380-384

  Akboğa, Mehmet Kadri ^a   Akyel, Ahmet ^b   Şahinarslan, Asife ^c   Yayla, C ^c   Alsancak, Yakup ^c   Gökalp, Gökhan ^c   Nurkoç, Serdar ^c   Abacı, Adnan ^c  

^a MINISTRY OF HEALTH   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Inflammation; Neutrophil to lymphocyte ratio; Rheumatic mitral valve disease

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INFLAMMATION; LEFT ATRIAL DIAMETER; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; NEUTROPHIL LYMPHOCYTE RATIO; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; EVALUATION STUDY; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PREDICTIVE VALUE; AGED; BLOOD CELL COUNT; CLINICAL PRACTICE; HEMOGLOBIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; REGRESSION ANALYSIS;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RHEUMATIC HEART DISEASE; ROC CURVE;

EID: 84979093285     PISSN: 13028723     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2014.5399     Document Type: Article

References (26)

1. Filgner CR, Reichenbach DD, Otto CM. Pathology and etiology of valvular heart disease. In: Otto CM, editor. Valvular Heart Disease. 2nd ed. Philadelphia: WB Saunders; 2004.p.30-3.
2. Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe rheumatic mitral valve disease in a developing country: Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann Intern Med 1994; 120: 177-83. [CrossRef]
3. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19: 1218-22. [CrossRef]
4. Gölbaşı Z, Uçar O, Keleş T, Şahin A, Cağlı K, Çamsarı A, et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 2002; 4: 593-5. [CrossRef]
5. Yetkin E, Erbay AR, İleri M, Turhan H, Balcı M, Çehreli S, et al. Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 2001; 88: 1209-11. [CrossRef]
6. Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003; 89: 1200-4. [CrossRef]
7. Kaya MG, Akpek M, Elçik D, Kalay N, Yarlioğlues M, Koç F, et al. Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers. Am J Cardiol 2012; 109: 851-5. [CrossRef]
8. Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 2005; 15: 266-71. [CrossRef]
9. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Arch Intern Med 2005; 165: 500-8. [CrossRef]
10. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43. [CrossRef]
11. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010; 105: 186-91. [CrossRef]
12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009; 10: 1-25. [CrossRef]
13. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 366: 155-68. [CrossRef]
14. Guilherme L, Cunha-Neto E, Coelho V, Snitcowsky R, Pomerantzeff PM, Assis RV, et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995; 92: 415-20. [CrossRef]
15. Stollerman GH. Rheumatologic streptococci and autoimmunity. Clin Immunol Immunopathol 1991; 61: 131-42. [CrossRef]
16. Alyan O, Metin F, Kaçmaz F, Özdemir O, Maden O, Topaloğlu S, et al. High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis. J Thromb Thrombolysis 2009; 28: 63-9. [CrossRef]
17. Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJ. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein. Int J Cardiol 2006; 109: 275-6. [CrossRef]
18. Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5-14.
19. Doğan M, Akyel A, Çimen T, Öksüz F, Çelik IE, Aytürk M, et al. Relationship between neutrophil-to-lymphocyte ratio and saphenous vein graft disease in patients with coronary bypass. Clin Appl Thromb Hemost 2013 May 7 [Epub ahead of print].
20. Öztürk S, Erdem A, Özlü MF, Ayhan S, Erdem K, Özyaşar M, et al. Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes. Turk Kardiyol Dern Ars 2013; 41: 284-9. [CrossRef]
21. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008; 395: 27-31. [CrossRef]
22. Sönmez O, Ertaş G, Bacaksız A, Taşal A, Erdoğan E, Asoğlu E, et al. Relation of neutrophil-to-lymphocyte ratio with the presence and complexity of coronary artery disease: an observational study. Anadolu Kardiyol Derg 2013; 13: 662-7.
23. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006; 97: 993-6. [CrossRef]
24. Turak O, Özcan F, İşleyen A, Başar FN, Gül M, Yılmaz S, et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis. Can J Cardiol 2013; 12: 1672-8. [CrossRef]
25. Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 1981; 13: 573-9. [CrossRef]
26. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-50. [CrossRef]